|
|
|
| CardioVascular |
|
|
EndoSpan
|
EndoSpan Ltd. Is a VC-backed clinical-stage medical device start-up, developing a novel endovascular system, intended to provide the next generation in Endo-Vascular Aortic Aneurysm repair (EVAR). EndoSpan's system aims to achieve a much smaller crossing profile compared with
contemporary devices. The system is intended for unilateral and purely percutaneous approach, thus simplifying and significantly shortening the procedure.
http://www.endospan.com
|
|
Cardiapex
|
Cardiapex Ltd. is an Israeli-based R&D-stage start-up company that is developing and will bring to market a novel trocar-like access and closure device that will facilitate transapical intra-cardiac procedures, including Transcatheter Aortic Valve Implantation (TAVI) and
Transcatheter Mitral Valve Implantation. Currently, in order to gain access to the apex for the purposes of transcatheter valve implantation, a 5-7 cm intercostal incision is made even though the catheters delivered through the apex itself require an opening less than 1cm across.
|
|
Pi-R Squared
|
Pi-R Squared Ltd. is a medical device start-up company developing a novel low profile catheter for the treatment of aortic stenosis. The company's proprietary technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the
surrounding soft tissue. This treatment, which only takes several seconds, is intended to increase the valve effective orifice area without the need to replace the valve.
|
|
Valcare Medical
|
Valcare Medical was founded in 2012 and is dedicated to designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve disease.
http://www.valcaremedical.com
|
|
|
| Orthopedics & Spine |
|
|
MCS (Medical Compression Systems)
|
MCS develops, manufactures and markets palm-size, battery-operated pneumatic compression therapy systems targeted at the DVT prevention field and is the first company to offer the market a new class of Continuous Enhanced Circulation Therapy (C.E.C.T) that can replace medication
therapy as the current standard of care. With the only clinically proven VTE (blood clot) prevention device to work independently of pharmaceutical agents - and with a price structure on par with drug cost - the company has already penetrated dozens of leading hospitals in the
U.S. The company's products are protected by numerous patents, have FDA clearance and are CE approved. MCS Inc., the company's subsidiary, is located in the U.S.
http://www.mcsmed.com
|
.png)
|
NLT SPINE
|
NLT Spine develops minimally invasive surgical (MIS) products for treating degenerative spinal conditions. Based on a patented "nonlinear" principle that allows large implants and instruments to be inserted through a small incision in the body, NLT Spine increases patient safety
and surgeon control while reducing postoperative complications. NLT Spine has nine patents issued and pending.
http://www.nonlinear-tech.com
|
|
CartiHeal
|
CartiHeal is the developer of proprietary, biocompatible and biodegradable off-the-shelf implants, for cartilage and bone regeneration. CartiHeal's acellular implant is arthroscopically press-fit within a cartilage or osteochondral defect in a single-stage procedure and supports
vessels formation followed by rapid invasion and adhesion of bone marrow mesenchymal stem cells. The CE marked implant has significant load-bearing capability, allowing patients faster rehabilitation.
|
|
|
| GI & Diabetics |
|
|
Endochoice
|
A global platform-technology company focused on Gastrointestinal (GI) endoscopy. Endochoice has merged with Accelmed's Peer Medical, a developer of a unique endoscopy technology to form a leading player in the GI industry. Endochoice is headquartered in Alpharetta, Georgia with
its R&D center based in Israel.
http://www.endochoice.com
|
|
|
| Surgical Technologies |
|
|
Eximo Medical
|
Eximo Medical Ltd. is an early stage start-up company founded in 2012. The company is developing a novel medical device based on a single use hybrid catheter for various medical applications that require precise and safe material removal. These applications have substantial and
growing markets.
|
|
|
|
|
|
|
Ophthalmic Imaging Systems (Sold to Merge Healthcare)
|
Ophthalmic Imaging Systems (OIS) is a leading provider of ophthalmic imaging and informatics solutions. OIS was the first investment of Accelmed (closed Q2/2009) and was sold two years later (Q2/2011) to Merge Healthcare (NASDAQ: MERGE).
http://www.merge.com
|
|
Edge Medical (Sold to Claymount)
|
Edge Medical Devices is the developer and manufacturer of Plasma DR flat-panel X-ray detector technology for digital radiography. Edge was the second investment of Accelmed (closed Q2/2009) and was sold two years later (Q3/2011) to Claymount, a leading multi-national X-ray player
backed by ABN-Amro.
http://www.claymount.com
|
|
PeerMedical (Merged with Endochoice)
|
Accelmed invested in Peer medical on Q2, 2010. Peer is, a developer of a proprietary video system and Full Spectrum Endoscope that greatly expands the field of view during endoscopy and colonoscopy, helping gastroenterologists detect more cancerous polyps and abnormal lesions.
Peer medical merged with Endochoice (Q4,2012), a global GI platform-technology company, and is now operating under the name of Endochoice, serving as its R&D center in Israel.
http://www.endochoice.com
|
|
|
|
|
|
